ALLE vs MLI

ALLE's Advanced Deterministic Scorecard shows a Piotroski F-Score of 4/9, indicating stable but not strong financial health, while the absence of an Altman Z-Score prevents a definitive distress risk assessment. The company trades above its Graham Number of $61.34 at a current price of $166.80, reflecting a significant premium, though justified in part by solid profitability metrics including a 36.41% ROE and consistent earnings growth. Despite strong historical earnings surprises and solid margins, elevated valuation multiples and bearish insider activity temper upside potential. Analysts concur with a 'hold' recommendation, aligning with the neutral stance.

MLI presents a stark contrast between absolute financial strength and deteriorating trend health, evidenced by a weak Piotroski F-Score of 3/9. While the company maintains a pristine balance sheet with near-zero debt (Debt/Equity 0.01) and exceptional ROE (28.30%), the low F-Score and bearish technical trend (10/100) suggest a loss of momentum. The stock trades at a significant premium to its Graham Number ($70.4) but remains below its growth-based intrinsic value ($225.09), with a high PEG ratio of 3.41 indicating potential overvaluation relative to growth. Recent insider selling and a poor earnings beat record (1/4 in the last year) further temper the bullish analyst consensus.